Immucise Intradermal Injection System

FDA 510(k) K181369 · Terumo Corporation

Substantially Equivalent

510(k) numberK181369

Submission

Device name
Immucise Intradermal Injection System
Applicant
Terumo Corporation
Shibuya-Ku, JP
Received
May 23, 2018
Decision date
November 13, 2018
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
FMI – Needle, Hypodermic, Single Lumen
Device class
Class II (moderate risk)
Regulation
21 CFR 880.5570
Specialty
General Hospital

Other 510(k)s with product code FMI

510(k)DeviceApplicantDecision
K261719Promisemed X-Safety Pen NeedleFMI · Special Promisemed Hangzhou Meditech Co., Ltd.08/25/2026SE
K262427Pen Needle (Ordinary Type I, Safety Type IIA, Safety Type IIB, Safety Type IIIA, Safety…FMI · Special Hh Global Technology, Inc.08/10/2026SE
K260933Safety Sterile Hypodermic Needles (NR-S1816R, NR-S1916R, NR-S1925R, NR-S1938R…FMI · Traditional Hangzhou Qiantang Longyue Biotechnology Co., Ltd.08/07/2026SE
K261829Profoject™ Dual-Safety Pen NeedlesFMI · Traditional CMT Health PTE., Ltd.07/29/2026SE
K260739Profoject™ Pen Needles (Model A; Model B)FMI · Traditional CMT Health PTE., Ltd.07/15/2026SE
K260855Profoject™ Safety Pen NeedlesFMI · Traditional CMT Health PTE., Ltd.06/10/2026SE
K254273Verisafe Safety Sterile Needles (SSN)FMI · Special Promisemed Hangzhou Meditech Co., Ltd.04/16/2026SE
K252908Easydrip Classic Pen Needle; Easydrip Plus Pen Needle; Easydrip Classic Pro Pen Needle…FMI · Special Sandstone Medical (Suzhou), Inc.03/25/2026SE
K253047Pressone™FMI · Traditional Nipro Medical Corporation03/24/2026SE
K253622Safety Pen NeedleFMI · Traditional Ningbo Medsun Medical Co., Ltd.03/18/2026SE

More from Ningbo Medsun Medical Co., Ltd.

510(k)DeviceDecision
K252295RyureiLOX · Traditional 03/27/2026SE
K250700Pen Injector Needle 32.5FMI · Traditional 11/21/2025SE
K250751DualView CatheterDQO · Traditional 07/17/2025SE
K240818R2P Radifocus Glidewire AdvantageDQX · Traditional 11/26/2024SE
K240859Glidewire GT-RDQX · Traditional 08/21/2024SE
K190427ImmuciseFMF · Traditional 07/18/2019SE
K173799NaviCross 0.018DQY · Traditional 03/29/2018SE
K170417Glidewire GTDQX · Traditional 09/15/2017SE
K130493Capiox RX05 Hollow Fiber Oxygenator/ReservoirDTZ · Special 03/13/2013SE
K130280Capiox FX Hollow Fiber Oxygenator W/ ReservoirDTZ · Special 03/13/2013SE

Questions and answers

When was Immucise Intradermal Injection System cleared by the FDA?

Immucise Intradermal Injection System (K181369) received a 510(k) decision of Substantially Equivalent on November 13, 2018, 174 days after the submission was received.

What is the product code of K181369?

The FDA product code is FMI – Needle, Hypodermic, Single Lumen, a Class II (moderate risk) device regulated under 21 CFR 880.5570.